buserelin has been researched along with ketoconazole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Jong, FH; Lamberts, SW; Uitterlinden, P | 1 |
Bailey, JD; Fazekas, AT; Fishman, L; Holland, FJ | 1 |
Baroncelli, GI; Bertelloni, S; Cappa, M; De Sanctis, C; Lala, R; Matarazzo, P; Saggese, G | 1 |
3 other study(ies) available for buserelin and ketoconazole
Article | Year |
---|---|
Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Topics: Adrenocorticotropic Hormone; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Goserelin; Imidazoles; Imidazolidines; Ketoconazole; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1988 |
Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Buserelin; Child Behavior; Child, Preschool; Drug Resistance; Follicle Stimulating Hormone; Growth; Humans; Hydroxyprogesterones; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Testosterone | 1985 |
Long-term outcome of male-limited gonadotropin-independent precocious puberty.
Topics: Androgen Antagonists; Buserelin; Child; Child, Preschool; Cyproterone Acetate; Drug Therapy, Combination; Follicle Stimulating Hormone; Humans; Ketoconazole; Luteinizing Hormone; Male; Puberty, Precocious; Receptors, LH; Testosterone | 1997 |